Observational studyInternational journal of molecular sciences2023

PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk.

Pere Rehues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.